Syphilis and congenital syphilis in Europe - A review of epidemiological trends (2007–2018) and options for response
Since 2010, syphilis notification rates in the EU/EAA have been on the increase, but in recent years this trend seems to accelerate predominantly among men having sex with men (MSM). Similar trends have been observed in high income c ountries outside the EU/EAA . While the overall trend remained relatively stable, outbreaks or clusters of syphilis cases have also been reported among heterosexual populations in the EU/EEA. In several high income countries (e.g. US A , increases in congenital syphilis occurred in connection with increases in syphilis notifications among women.
Syphilis notifications in the EU/EEA up by 70% since 2010
The number of syphilis cases has been consistently going up across Europe since 2010, mostly affecting men who have sex with men living in urban areas. In 2017, notification rates reached an all-time high in the EU/EEA countries with more than 33 000 reported cases. An in-depth ECDC study published today describes the factors behind this increase and outlines the evidence-based options for public health control of syphilis, including case finding and management as well as educational activities.
ECDC’s HEPSA preparedness self-assessment tool is now available in all EU/EEA languages
The HEPSA (Health Emergency Preparedness Self-Assessment) tool that ECDC launched in 2018 in English is now available in all EU/EEA languages. This tool aims at supporting countries in improving their level of public health emergency preparedness.
Lymphogranuloma venereum (LGV) in men who have sex with men (MSM): A re-emerging problem, Malta, 2018
Donachie, A., Spiteri, G., Barbara, C., Melillo, T., Hadad, R., Farrugia, A.G., Unemo, M., Padovese, V.
HEPSA – health emergency preparedness self-assessment tool, User guide
HEPSA is used to evaluate levels of preparedness, identify potential gaps, identify vulnerabilities, and detect areas for improvement – with the goal to strengthen overall preparedness capacities for public health emergencies. This user guide provides basic information on the self-assessment process.
Potential adjustment methodology for missing data and reporting delay in the HIV surveillance system, European Union/European Economic Area, 2015
Rosinska, M., Pantazis, N., Janiec, J., Pharris, A., Amato-Gauci, A.J., Quinten, C., Schmid, D., Sasse, A., van Beckhoven, D., Varleva, T., Blazic, T.N., Hadjihannas, L., Koliou, M., Maly, M., Cowan, S., Rüütel, K., Liitsola, K., Salminen, M., Cazein, F., Pillonel, J., Lot, F., Gunsenheimer-Bartmeyer, B., Nikolopoulos, G., Paraskeva, D., Dudas, M., Briem, H., Sigmundsdottir, G., Igoe, D., O’Donnell, K., O’Flanagan, D., Suligoi, B., Konova, Š., Erne, S., Čaplinskienė, I., Schmit, A.F.J.-C., Melillo, J.M., Melillo, T., de Coul, E.O., van Sighem, A., Blystad, H., Rosinska, M., Aldir, I., Martins, H.C., Mardarescu, M., Truska, P., Klavs, I., Diaz, A., Axelsson, M., Delpech, V.
ECDC: first detected cases of extensively drug-resistant gonorrhoea threaten future treatment
Within a matter of weeks, three cases of gonorrhoea that are resistant to the recommended first line antibiotic treatment have been detected in Europe and Australia. These are the first global reports of Neisseria gonorrhoeae with high-level resistance to azithromycin and ceftriaxone resistance that also show resistance to several other vital antibiotics. At a time with limited alternatives to the current dual therapy, lack of a vaccine and insufficient surveillance capacity in some regions, these cases highlight the growing threat of drug-resistance – which could lead to untreatable gonorrhoea.